Clinical trials
Phase 1 trials in Germany with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heidelberg University | 4 |
| University Hospital Tuebingen | 3 |
| University Hospital, Bonn | 3 |
| Heinrich-Heine University, Duesseldorf | 2 |
| Medical University Innsbruck | 2 |
| Technical University of Munich | 2 |
| University of Cologne | 2 |
| University of Rostock | 2 |
| Axon Neuroscience SE | 1 |
| Central European Society for Anticancer Drug Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 3 |
| Ovarian Neoplasms | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Recurrence | 2 |
| Angina Pectoris | 1 |
| Anterior Cruciate Ligament Injuries | 1 |
| Aphasia, Primary Progressive | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colonic Neoplasms | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.